June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days
Author Affiliations & Notes
  • Christina E Morettin
    Illinois College of Optometry, Chicago, Illinois, United States
  • Jennifer S Harthan
    Illinois College of Optometry, Chicago, Illinois, United States
  • Julia Huecker
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • AA Chamila D Perera
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Tammy P Than
    Carl Vinson VA Medical Center, Dublin, Georgia, United States
  • Ellen Shorter
    University of Illinois Hospital and Health Sciences System, Chicago, Illinois, United States
  • Meredith Whiteside
    University of California Berkeley, Berkeley, California, United States
  • Spencer Johnson
    Northeastern State University College of Optometry, Tahlequah, Oklahoma, United States
  • Andrew Hartwick
    Optometry, The Ohio State University, Columbus, Ohio, United States
  • Mathew Margolis
    University of Illinois Hospital and Health Sciences System, Chicago, Illinois, United States
  • Mary K Migneco
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Christopher Alferez
    US Army Brooke Army Medical Center, Fort Sam Houston, Texas, United States
  • Devon Camp
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Len Haertter
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Mae O Gordon
    Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Footnotes
    Commercial Relationships   Christina Morettin, None; Jennifer Harthan, None; Julia Huecker, None; AA Chamila Perera, None; Tammy Than, None; Ellen Shorter, None; Meredith Whiteside, None; Spencer Johnson, None; Andrew Hartwick, None; Mathew Margolis, None; Mary Migneco, None; Christopher Alferez, None; Devon Camp, None; Len Haertter, None; Mae Gordon, None
  • Footnotes
    Support  National Eye Institute Center R34 Grant (EY023633-01A1), a National Eye Institute Center Core Grant (P30EY002687) and an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 696. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christina E Morettin, Jennifer S Harthan, Julia Huecker, AA Chamila D Perera, Tammy P Than, Ellen Shorter, Meredith Whiteside, Spencer Johnson, Andrew Hartwick, Mathew Margolis, Mary K Migneco, Christopher Alferez, Devon Camp, Len Haertter, Mae O Gordon; Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days. Invest. Ophthalmol. Vis. Sci. 2021;62(8):696.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the correlation of viral load at baseline and over 21 days with severity of signs, symptoms, and viral clearance in participants with adenoviral conjunctivitis.

Methods : Of 212 participants screened for adenoviral conjunctivitis (Ad-Cs), 56 met the following criteria and were randomized: ≥ 18 years of age, symptoms ≤ 4 days, a positive point-of-care immunoassay via AdenoPlusTM (Quidel, San Diego CA). One eye of each participant was randomized to a single, in-office administration of either 5% povidone-iodine (PVP-I) or artificial tears (AT). Examinations at baseline, days 1-2, 4, 7, 14, and 21 included assessment of participant symptoms, clinician graded signs, and conjunctival swabs for qPCR analysis. Repeated measures generalized estimating equations were used for calculating the correlation (r) of viral load with signs and symptoms over 21 days. Severity of signs and symptoms is reported for 3 equal size tertiles of baseline viral load: low (log qPCR <6.13), middle (log qPCR 6.13-6.78) and high (log qPCR >6.78).

Results : Twenty-five participants were qPCR positive for adenovirus and had sufficient follow-up visits. Viral load was not correlated with participant symptoms or clinician graded signs at baseline. However, higher viral load over 21 days had correlations with increased severity of participant symptoms of tearing, matting and redness (r≥0.70; p<0.02) and with clinician graded signs of bulbar redness and serous discharge (r≥0.60; p<0.01). Higher baseline titers were correlated with longer time to viral clearance (r=0.59, p=0.0075). Days to viral clearance in low, middle and high baseline viral titer tertiles were 10.3 + 5.6, 9.5 + 3.5, and 19.8 + 3.8, respectively. The incidence of subepithelial infiltrates or pseudomembranes was higher in the highest tertile of viral load (75%, 6 of 8) compared to the lowest tertile (40%, 4 of 10, p=0.43).

Conclusions : High correlations were found between viral load with more severe signs and symptoms over 21 days. Higher baseline viral load was associated with longer time to viral clearance.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×